These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 12563775
21. Mapping of the antigenic determinants of the Leishmania infantum gp63 protein recognized by antibodies elicited during canine visceral leishmaniasis. Morales G, Carrillo G, Requena JM, Guzman F, Gomez LC, Patarroyo ME, Alonso C. Parasitology; 1997 Jun; 114 ( Pt 6)():507-16. PubMed ID: 9172421 [Abstract] [Full Text] [Related]
24. The role of CpG ODN in enhancement of immune response and protection in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in cationic liposome. Jaafari MR, Badiee A, Khamesipour A, Samiei A, Soroush D, Kheiri MT, Barkhordari F, McMaster WR, Mahboudi F. Vaccine; 2007 Aug 10; 25(32):6107-17. PubMed ID: 17629372 [Abstract] [Full Text] [Related]
25. Expression of recombinant heat-shock protein 70 of MCAN/IR/96/LON-49, a tool for diagnosis and future vaccine research. Rasouli M, Zavaran Hoseini A, Kazemi B, Alborzi A, Kiany S. Iran J Immunol; 2009 Jun 10; 6(2):75-86. PubMed ID: 19561376 [Abstract] [Full Text] [Related]
26. Infection with Leishmania infantum Inhibits actinomycin D-induced apoptosis of human monocytic cell line U-937. Lisi S, Sisto M, Acquafredda A, Spinelli R, Schiavone M, Mitolo V, Brandonisio O, Panaro M. J Eukaryot Microbiol; 2005 Jun 10; 52(3):211-7. PubMed ID: 15926996 [Abstract] [Full Text] [Related]
29. Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis. Rafati S, Zahedifard F, Nazgouee F. Vaccine; 2006 Mar 15; 24(12):2169-75. PubMed ID: 16325969 [Abstract] [Full Text] [Related]
30. Comparative study of infectivity caused by promastigotes of Leishmania infantum MON-1, L. infantum MON-24 and L. donovani MON-18. Santos-Gomes GM, Abranches P. Folia Parasitol (Praha); 1996 Mar 15; 43(1):7-12. PubMed ID: 8682411 [Abstract] [Full Text] [Related]
31. Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB/c mice. Jaafari MR, Ghafarian A, Farrokh-Gisour A, Samiei A, Kheiri MT, Mahboudi F, Barkhordari F, Khamesipour A, McMaster WR. Vaccine; 2006 Jul 17; 24(29-30):5708-17. PubMed ID: 16740346 [Abstract] [Full Text] [Related]
32. The FML-vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine. Saraiva EM, de Figueiredo Barbosa A, Santos FN, Borja-Cabrera GP, Nico D, Souza LO, de Oliveira Mendes-Aguiar C, de Souza EP, Fampa P, Parra LE, Menz I, Dias JG, de Oliveira SM, Palatnik-de-Sousa CB. Vaccine; 2006 Mar 20; 24(13):2423-31. PubMed ID: 16386824 [Abstract] [Full Text] [Related]
35. Vaccination with a novel recombinant Leishmania antigen plus MPL provides partial protection against L. donovani challenge in experimental model of visceral leishmaniasis. Bhardwaj S, Vasishta RK, Arora SK. Exp Parasitol; 2009 Jan 20; 121(1):29-37. PubMed ID: 18983842 [Abstract] [Full Text] [Related]
37. Serological evaluation of experimentally infected dogs by LicTXNPx-ELISA and amastigote-flow cytometry. Silvestre R, Santarém N, Cunha J, Cardoso L, Nieto J, Carrillo E, Moreno J, Cordeiro-da-Silva A. Vet Parasitol; 2008 Nov 25; 158(1-2):23-30. PubMed ID: 18848397 [Abstract] [Full Text] [Related]